Paraneoplastic Polyarthritis in Hepatocellular Carcinoma Treated With Lenvatinib
Sign Up to like & getrecommendations! Published in 2021 at "Hepatology"
DOI: 10.1002/hep.31794
Abstract: A 79-year old male was admitted to hospital for weight loss and polyarthritis. Examination revealed warmth, erythema and swelling of the left metacarpophalangeal joints, wrist, right shoulder and ankle. The CRP was elevated at 109… read more here.
Keywords: polyarthritis hepatocellular; hepatocellular carcinoma; paraneoplastic polyarthritis; polyarthritis ... See more keywords
Prognostic significance of sarcopenia in patients with hepatocellular carcinoma treated with lenvatinib
Sign Up to like & getrecommendations! Published in 2022 at "Medicine"
DOI: 10.1097/md.0000000000028680
Abstract: Abstract Our study investigated the correlation between sarcopenia and clinical outcomes in patients with hepatocellular carcinoma (HCC) treated with lenvatinib. We retrospectively evaluated 40 consecutive patients with unresectable HCC receiving lenvatinib between November 2018 and… read more here.
Keywords: hepatocellular carcinoma; sarcopenia; prognostic significance; treated lenvatinib ... See more keywords
Prevalence and Risk Factors of Developing Fistula or Organ Perforation in Patients Treated with Lenvatinib for Radioiodine-Refractory Thyroid Cancer
Sign Up to like & getrecommendations! Published in 2021 at "European Thyroid Journal"
DOI: 10.1159/000514182
Abstract: Introduction: Tyrosine kinase inhibitors represent a better treatment in patients with radioiodine-refractory differentiated thyroid cancer (RAI-R DTC). Lenvatinib is usually well-tolerated, but sometimes, it is associated with serious and even life-threatening side effects. The aim… read more here.
Keywords: organ perforation; patients treated; perforation; thyroid cancer ... See more keywords
Baseline Tumour Size as a Prognostic Factor for Radioiodine-refractory Differentiated Thyroid Cancer Treated With Lenvatinib
Sign Up to like & getrecommendations! Published in 2021 at "AntiCancer Research"
DOI: 10.21873/anticanres.14932
Abstract: Background/Aim: Lenvatinib is standard therapy for radioiodine-refractory differentiated thyroid cancer (RR-DTC), although the optimal timing for starting treatment is still controversial. The aim of this study was to evaluate the prognostic impact of baseline tumour… read more here.
Keywords: baseline tumour; refractory differentiated; differentiated thyroid; thyroid cancer ... See more keywords
Neutrophil-to-Lymphocyte Ratio as a Prognostic Marker for Anaplastic Thyroid Cancer Treated With Lenvatinib
Sign Up to like & getrecommendations! Published in 2020 at "In Vivo"
DOI: 10.21873/invivo.12113
Abstract: Background/Aim: Lenvatinib is one of the few options for patients with anaplastic thyroid cancer (ATC). However, tumor markers for ATC treated with lenvatinib is lacking. The aim of this study was to explore whether the… read more here.
Keywords: anaplastic thyroid; neutrophil lymphocyte; thyroid cancer; lymphocyte ratio ... See more keywords
Effect of Handgrip Strength on Clinical Outcomes of Patients with Hepatocellular Carcinoma Treated with Lenvatinib
Sign Up to like & getrecommendations! Published in 2020 at "Applied Sciences"
DOI: 10.3390/app10165403
Abstract: Previous studies have reported prognostic factors for hepatocellular carcinoma (HCC) patients receiving lenvatinib; however, no studies have evaluated the effects of both handgrip strength and skeletal muscle mass on the clinical outcomes. Therefore, this retrospective… read more here.
Keywords: strength; clinical outcomes; muscle; treated lenvatinib ... See more keywords
Role of Etiology in Hepatocellular Carcinoma Patients Treated with Lenvatinib: A Counterfactual Event-Based Mediation Analysis
Sign Up to like & getrecommendations! Published in 2023 at "Cancers"
DOI: 10.3390/cancers15020381
Abstract: Simple Summary Hepatocellular carcinoma is the fifth most common cancer worldwide. For patients with advanced hepatocellular carcinoma, therapeutic options are limited. Lenvatinib has proven to be an effective option for treating advanced diseases. For patients… read more here.
Keywords: hepatocellular carcinoma; treated lenvatinib; viral etiology; etiology ... See more keywords